{
  "doc_id": "35",
  "paragraphs": [
    {
      "paragraph_id": "0",
      "paragraph": "评中国成人2型糖尿病胰岛素促泌剂应用专家共识 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "评中国成人2型糖尿病胰岛素促泌剂应用专家共识 ",
          "start_idx": 0,
          "end_idx": 23,
          "entities": [
            {
              "entity_id": "T0",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 5,
              "end_idx": 10
            },
            {
              "entity_id": "T1",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 5,
              "end_idx": 7
            },
            {
              "entity_id": "T2",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 10,
              "end_idx": 16
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R0",
              "head_entity_id": "T1",
              "tail_entity_id": "T0"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R1",
              "head_entity_id": "T2",
              "tail_entity_id": "T0"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "1",
      "paragraph": "胰岛素促泌剂是临床应用最早、最广泛的口服降糖药之一，降糖疗效肯定、安全性高、价格低廉、可与其他口服降糖药联用，在2型糖尿病(T2DM)治疗中占有重要地位，是多数国际权威人T2DM防治指南中的一线降糖药物。为了强调其重要性及正确认识和评价这一大类降糖药、中华医学会内分泌学分会于2011年讨论通过了《中国成人2型糖尿病胰岛素促泌剂应用的专家共识》，并于2012年正式表发。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "胰岛素促泌剂是临床应用最早、最广泛的口服降糖药之一，降糖疗效肯定、安全性高、价格低廉、可与其他口服降糖药联用，在2型糖尿病(T2DM)治疗中占有重要地位，是多数国际权威人T2DM防治指南中的一线降糖药物。为了强调其重要性及正确认识和评价这一大类降糖药、中华医学会内分泌学分会于2011年讨论通过了《中国成人2型糖尿病胰岛素促泌剂应用的专家共识》，并于2012年正式表发。",
          "start_idx": 0,
          "end_idx": 185,
          "entities": [
            {
              "entity_id": "T3",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 6
            },
            {
              "entity_id": "T4",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 18,
              "end_idx": 20
            },
            {
              "entity_id": "T5",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 47,
              "end_idx": 49
            },
            {
              "entity_id": "T6",
              "entity": "2型糖尿病(T2DM)",
              "entity_type": "Disease",
              "start_idx": 56,
              "end_idx": 67
            },
            {
              "entity_id": "T7",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 56,
              "end_idx": 58
            },
            {
              "entity_id": "T8",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 85,
              "end_idx": 89
            },
            {
              "entity_id": "T9",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 153,
              "end_idx": 158
            },
            {
              "entity_id": "T10",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 153,
              "end_idx": 155
            },
            {
              "entity_id": "T11",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 158,
              "end_idx": 164
            },
            {
              "entity_id": "T12",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 85,
              "end_idx": 87
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R2",
              "head_entity_id": "T4",
              "tail_entity_id": "T3"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R3",
              "head_entity_id": "T7",
              "tail_entity_id": "T6"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R4",
              "head_entity_id": "T12",
              "tail_entity_id": "T8"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R5",
              "head_entity_id": "T10",
              "tail_entity_id": "T9"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R6",
              "head_entity_id": "T11",
              "tail_entity_id": "T9"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 185,
          "end_idx": 186,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "2",
      "paragraph": "1 胰岛素促泌剂的作用机制及特点 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1 胰岛素促泌剂的作用机制及特点 ",
          "start_idx": 0,
          "end_idx": 17,
          "entities": [
            {
              "entity_id": "T13",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 8
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "3",
      "paragraph": "目前国内使用的胰岛素促泌剂包括磺脲类和格列奈类。磺脲类促泌剂包括半衰期较短的短效促泌剂(如格列吡嗪和格列喹酮)和半衰期较长的中长效促泌剂(如普通剂型的格列美脲、格列苯脲和格列齐特，以及通过特殊的胃肠道治疗系统(GITS)技术实现控释的格列吡嗪控释片和采用以亲水性羟丙甲纤维素为基质的缓释技术格列齐特缓释片)。格列奈类半衰期较短，属短效促剂，包括瑞格列奈和那格列奈。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "目前国内使用的胰岛素促泌剂包括磺脲类和格列奈类。",
          "start_idx": 0,
          "end_idx": 24,
          "entities": [
            {
              "entity_id": "T14",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 13
            },
            {
              "entity_id": "T15",
              "entity": "磺脲类",
              "entity_type": "Drug",
              "start_idx": 15,
              "end_idx": 18
            },
            {
              "entity_id": "T16",
              "entity": "格列奈类",
              "entity_type": "Drug",
              "start_idx": 19,
              "end_idx": 23
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "磺脲类促泌剂包括半衰期较短的短效促泌剂(如格列吡嗪和格列喹酮)和半衰期较长的中长效促泌剂(如普通剂型的格列美脲、格列苯脲和格列齐特，以及通过特殊的胃肠道治疗系统(GITS)技术实现控释的格列吡嗪控释片和采用以亲水性羟丙甲纤维素为基质的缓释技术格列齐特缓释片)。",
          "start_idx": 24,
          "end_idx": 154,
          "entities": [
            {
              "entity_id": "T17",
              "entity": "磺脲类促泌剂",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 6
            },
            {
              "entity_id": "T18",
              "entity": "格列吡嗪",
              "entity_type": "Drug",
              "start_idx": 21,
              "end_idx": 25
            },
            {
              "entity_id": "T19",
              "entity": "格列喹酮",
              "entity_type": "Drug",
              "start_idx": 26,
              "end_idx": 30
            },
            {
              "entity_id": "T20",
              "entity": "格列美脲",
              "entity_type": "Drug",
              "start_idx": 51,
              "end_idx": 55
            },
            {
              "entity_id": "T21",
              "entity": "格列苯脲",
              "entity_type": "Drug",
              "start_idx": 56,
              "end_idx": 60
            },
            {
              "entity_id": "T22",
              "entity": "格列齐特",
              "entity_type": "Drug",
              "start_idx": 61,
              "end_idx": 65
            },
            {
              "entity_id": "T23",
              "entity": "格列吡嗪控释片",
              "entity_type": "Drug",
              "start_idx": 93,
              "end_idx": 100
            },
            {
              "entity_id": "T24",
              "entity": "格列齐特缓释片",
              "entity_type": "Drug",
              "start_idx": 121,
              "end_idx": 128
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "格列奈类半衰期较短，属短效促剂，包括瑞格列奈和那格列奈。",
          "start_idx": 154,
          "end_idx": 182,
          "entities": [
            {
              "entity_id": "T25",
              "entity": "格列奈类",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4
            },
            {
              "entity_id": "T26",
              "entity": "瑞格列奈",
              "entity_type": "Drug",
              "start_idx": 18,
              "end_idx": 22
            },
            {
              "entity_id": "T27",
              "entity": "那格列奈",
              "entity_type": "Drug",
              "start_idx": 23,
              "end_idx": 27
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "3",
          "sentence": " ",
          "start_idx": 182,
          "end_idx": 183,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "4",
      "paragraph": "磺脲类促泌剂通过与β细胞膜三磷酸腺苷(ATP)敏感的钾通道(KATP)的磺脲类药物受体(SUR)结合，ATP/ADP比值升高，KATP通道关闭，细胞内的K+外流受阻，胞内K+升高、细胞膜去极化，触发L2型电压依赖的Ca2+通道开放，细胞外Ca2+内流增加，胞质内Ca2+浓度升高，从而刺激胰岛素分泌颗粒向细胞外分泌。KATP通道也存在于大脑、心肌和血管平滑肌等组织。不同组织的SUR存在差异，不同胰岛素促泌剂会与β细胞不同分子量的SUR受体结合，且亲和力和解离速度也各不相同，这些是其产生药效学差异的原因。格列本脲可作用于SUR1和SUR2A，而格列齐特仅作用于SUR1。格列本脲和格列美脲各自与SUR1不同亚单位特异性结合，格列美脲与SUR的亲和力更强、结合和解离速度也更快。格列本脲与两个SUR1位点相结合，不易与受体脱离，且作用时间相对较长。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "磺脲类促泌剂通过与β细胞膜三磷酸腺苷(ATP)敏感的钾通道(KATP)的磺脲类药物受体(SUR)结合，ATP/ADP比值升高，KATP通道关闭，细胞内的K+外流受阻，胞内K+升高、细胞膜去极化，触发L2型电压依赖的Ca2+通道开放，细胞外Ca2+内流增加，胞质内Ca2+浓度升高，从而刺激胰岛素分泌颗粒向细胞外分泌。",
          "start_idx": 0,
          "end_idx": 158,
          "entities": [
            {
              "entity_id": "T28",
              "entity": "磺脲类促泌剂",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 6
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "KATP通道也存在于大脑、心肌和血管平滑肌等组织。",
          "start_idx": 158,
          "end_idx": 183,
          "entities": [],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "不同组织的SUR存在差异，不同胰岛素促泌剂会与β细胞不同分子量的SUR受体结合，且亲和力和解离速度也各不相同，这些是其产生药效学差异的原因。",
          "start_idx": 183,
          "end_idx": 253,
          "entities": [
            {
              "entity_id": "T29",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 15,
              "end_idx": 21
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "3",
          "sentence": "格列本脲可作用于SUR1和SUR2A，而格列齐特仅作用于SUR1。",
          "start_idx": 253,
          "end_idx": 286,
          "entities": [
            {
              "entity_id": "T30",
              "entity": "格列本脲",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4
            },
            {
              "entity_id": "T31",
              "entity": "格列齐特",
              "entity_type": "Drug",
              "start_idx": 20,
              "end_idx": 24
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "4",
          "sentence": "格列本脲和格列美脲各自与SUR1不同亚单位特异性结合，格列美脲与SUR的亲和力更强、结合和解离速度也更快。",
          "start_idx": 286,
          "end_idx": 339,
          "entities": [
            {
              "entity_id": "T32",
              "entity": "格列本脲",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4
            },
            {
              "entity_id": "T33",
              "entity": "格列美脲",
              "entity_type": "Drug",
              "start_idx": 5,
              "end_idx": 9
            },
            {
              "entity_id": "T34",
              "entity": "格列美脲",
              "entity_type": "Drug",
              "start_idx": 27,
              "end_idx": 31
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "5",
          "sentence": "格列本脲与两个SUR1位点相结合，不易与受体脱离，且作用时间相对较长。",
          "start_idx": 339,
          "end_idx": 374,
          "entities": [
            {
              "entity_id": "T35",
              "entity": "格列本脲",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "5",
      "paragraph": "近年来，通过对β细胞的电压钳研究证实，磺脲类药物可不作用于KATP而直接加强Ca2+依赖的胰岛素分泌作用。通过葡萄糖钳夹技术研究发现，磺脲类药物可使人体外周葡萄糖利用增加10%~52%(平均29%)。但促泌剂改善胰岛素敏感性的作用主要继发于葡萄糖毒性作用的改善。不同的促泌剂对胰岛素敏感性的影响可能存在差异，如格列美脲在离体培养的脂肪细胞和肌肉组织中具有直接的拟胰岛素和胰岛素增敏作用。有研究表明，磺脲类促泌剂还可以通过其他机制降低血糖，其降低空腹血糖的作用与其抑制基础肝糖的生成密切相关。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "近年来，通过对β细胞的电压钳研究证实，磺脲类药物可不作用于KATP而直接加强Ca2+依赖的胰岛素分泌作用。",
          "start_idx": 0,
          "end_idx": 53,
          "entities": [
            {
              "entity_id": "T36",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 19,
              "end_idx": 24
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "通过葡萄糖钳夹技术研究发现，磺脲类药物可使人体外周葡萄糖利用增加10%~52%(平均29%)。",
          "start_idx": 53,
          "end_idx": 100,
          "entities": [
            {
              "entity_id": "T37",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 14,
              "end_idx": 19
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "但促泌剂改善胰岛素敏感性的作用主要继发于葡萄糖毒性作用的改善。",
          "start_idx": 100,
          "end_idx": 131,
          "entities": [],
          "relations": []
        },
        {
          "sentence_id": "3",
          "sentence": "不同的促泌剂对胰岛素敏感性的影响可能存在差异，如格列美脲在离体培养的脂肪细胞和肌肉组织中具有直接的拟胰岛素和胰岛素增敏作用。",
          "start_idx": 131,
          "end_idx": 193,
          "entities": [
            {
              "entity_id": "T38",
              "entity": "格列美脲",
              "entity_type": "Drug",
              "start_idx": 24,
              "end_idx": 28
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "4",
          "sentence": "有研究表明，磺脲类促泌剂还可以通过其他机制降低血糖，其降低空腹血糖的作用与其抑制基础肝糖的生成密切相关。",
          "start_idx": 193,
          "end_idx": 245,
          "entities": [
            {
              "entity_id": "T39",
              "entity": "磺脲类促泌剂",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 12
            },
            {
              "entity_id": "T40",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 23,
              "end_idx": 25
            },
            {
              "entity_id": "T41",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 29,
              "end_idx": 33
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "5",
          "sentence": " ",
          "start_idx": 245,
          "end_idx": 246,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "6",
      "paragraph": "格列奈类药物也与胰岛β细胞膜SUR结合，与磺脲类药物相比，促胰岛素分泌作用起效快、作用持续时间短，有效降低餐后血糖，同时不增加胰岛素分泌总量，不加重β细胞负荷，低血糖的发生率低。胰岛素促泌剂降糖主要与对β细胞的作用有关，胰外作用不如对β细胞的作用重要。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "格列奈类药物也与胰岛β细胞膜SUR结合，与磺脲类药物相比，促胰岛素分泌作用起效快、作用持续时间短，有效降低餐后血糖，同时不增加胰岛素分泌总量，不加重β细胞负荷，低血糖的发生率低。",
          "start_idx": 0,
          "end_idx": 89,
          "entities": [
            {
              "entity_id": "T42",
              "entity": "格列奈类药物",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 6
            },
            {
              "entity_id": "T43",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 21,
              "end_idx": 26
            },
            {
              "entity_id": "T45",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 53,
              "end_idx": 57
            },
            {
              "entity_id": "T46",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 80,
              "end_idx": 83
            }
          ],
          "relations": [
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R7",
              "head_entity_id": "T46",
              "tail_entity_id": "T42"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "胰岛素促泌剂降糖主要与对β细胞的作用有关，胰外作用不如对β细胞的作用重要。",
          "start_idx": 89,
          "end_idx": 126,
          "entities": [
            {
              "entity_id": "T44",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 6
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "7",
      "paragraph": "2 对胰岛素促泌剂认识的误区 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2 对胰岛素促泌剂认识的误区 ",
          "start_idx": 0,
          "end_idx": 15,
          "entities": [
            {
              "entity_id": "T47",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 9
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "8",
      "paragraph": "2.1 低血糖风险高",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.1 低血糖风险高",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [
            {
              "entity_id": "T48",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 4,
              "end_idx": 7
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "9",
      "paragraph": "低血糖是磺脲类药物最常见的不良反度。但剂型改良后的格列吡嗪控释片、格列齐特缓释片和格列美脲等中长效制剂及餐时血糖调节药格列奈类，因其较低的血药浓度和依赖葡萄糖的降糖作用，低血糖的发生率低。GUIDE结果显示，在血糖水平控制相似的情况下，不同磺脲类促泌剂所致低血糖发生风险不同。糖尿病和心血管疾病行动研究(ADVANCE)以格列齐特缓释片为基瑞的降糖治疗严重低血糖年发生率仅为英国前瞻性糖尿病研究(UKPDS)采用格列本脲和氯磺丙脲为基碗的降糖治疗的1/4。英国一般实践研究数据库表明，磺脲类药物使用者年低血糖的发生半为1.8%，其中2.0%为年龄>65岁。在磺脲类药物中，格列苯脲的低血糖发生率最高，格列齐特和格列吡嗪的低血糖发生风险比格列苯脲低25%和40%。UKPDS对使用氯磺丙脲、格列苯脲和胰岛素的T2DM患者进行10年的随访表明，其年低血糖的发生率分别为11.0%、17.7%和36.5%。公认的低血糖发生少的甘精胰岛素的大型研究最新结果显示，甘精胰岛素低血糖发生的风险明显高于口服药。由此可见，胰岛素促泌剂肯定存在低血糖风险，但是胰岛素的低血糖风险更大。因此需要时一般情况下应优先选择胰岛素促泌剂而不是胰岛素。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "低血糖是磺脲类药物最常见的不良反度。但剂型改良后的格列吡嗪控释片、格列齐特缓释片和格列美脲等中长效制剂及餐时血糖调节药格列奈类，因其较低的血药浓度和依赖葡萄糖的降糖作用，低血糖的发生率低。GUIDE结果显示，在血糖水平控制相似的情况下，不同磺脲类促泌剂所致低血糖发生风险不同。糖尿病和心血管疾病行动研究(ADVANCE)以格列齐特缓释片为基瑞的降糖治疗严重低血糖年发生率仅为英国前瞻性糖尿病研究(UKPDS)采用格列本脲和氯磺丙脲为基碗的降糖治疗的1/4。英国一般实践研究数据库表明，磺脲类药物使用者年低血糖的发生半为1.8%，其中2.0%为年龄>65岁。在磺脲类药物中，格列苯脲的低血糖发生率最高，格列齐特和格列吡嗪的低血糖发生风险比格列苯脲低25%和40%。UKPDS对使用氯磺丙脲、格列苯脲和胰岛素的T2DM患者进行10年的随访表明，其年低血糖的发生率分别为11.0%、17.7%和36.5%。",
          "start_idx": 0,
          "end_idx": 400,
          "entities": [
            {
              "entity_id": "T49",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 4,
              "end_idx": 9
            },
            {
              "entity_id": "T50",
              "entity": "格列吡嗪控释片",
              "entity_type": "Drug",
              "start_idx": 25,
              "end_idx": 32
            },
            {
              "entity_id": "T51",
              "entity": "格列齐特缓释片",
              "entity_type": "Drug",
              "start_idx": 33,
              "end_idx": 40
            },
            {
              "entity_id": "T52",
              "entity": "格列美脲",
              "entity_type": "Drug",
              "start_idx": 41,
              "end_idx": 45
            },
            {
              "entity_id": "T53",
              "entity": "格列奈类",
              "entity_type": "Drug",
              "start_idx": 59,
              "end_idx": 63
            },
            {
              "entity_id": "T54",
              "entity": "磺脲类促泌剂",
              "entity_type": "Drug",
              "start_idx": 120,
              "end_idx": 126
            },
            {
              "entity_id": "T55",
              "entity": "格列齐特缓释片",
              "entity_type": "Drug",
              "start_idx": 161,
              "end_idx": 168
            },
            {
              "entity_id": "T56",
              "entity": "格列本脲",
              "entity_type": "Drug",
              "start_idx": 206,
              "end_idx": 210
            },
            {
              "entity_id": "T57",
              "entity": "氯磺丙脲",
              "entity_type": "Drug",
              "start_idx": 211,
              "end_idx": 215
            },
            {
              "entity_id": "T58",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 242,
              "end_idx": 247
            },
            {
              "entity_id": "T59",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 279,
              "end_idx": 284
            },
            {
              "entity_id": "T60",
              "entity": "格列苯脲",
              "entity_type": "Drug",
              "start_idx": 286,
              "end_idx": 290
            },
            {
              "entity_id": "T61",
              "entity": "格列齐特",
              "entity_type": "Drug",
              "start_idx": 300,
              "end_idx": 304
            },
            {
              "entity_id": "T62",
              "entity": "格列吡嗪",
              "entity_type": "Drug",
              "start_idx": 305,
              "end_idx": 309
            },
            {
              "entity_id": "T63",
              "entity": "格列苯脲",
              "entity_type": "Drug",
              "start_idx": 318,
              "end_idx": 322
            },
            {
              "entity_id": "T64",
              "entity": "氯磺丙脲",
              "entity_type": "Drug",
              "start_idx": 339,
              "end_idx": 343
            },
            {
              "entity_id": "T65",
              "entity": "格列苯脲",
              "entity_type": "Drug",
              "start_idx": 344,
              "end_idx": 348
            },
            {
              "entity_id": "T66",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 349,
              "end_idx": 352
            },
            {
              "entity_id": "T73",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 0,
              "end_idx": 3
            },
            {
              "entity_id": "T74",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 85,
              "end_idx": 88
            },
            {
              "entity_id": "T75",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 128,
              "end_idx": 131
            },
            {
              "entity_id": "T76",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 178,
              "end_idx": 181
            },
            {
              "entity_id": "T77",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 251,
              "end_idx": 254
            },
            {
              "entity_id": "T78",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 291,
              "end_idx": 294
            },
            {
              "entity_id": "T79",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 310,
              "end_idx": 313
            },
            {
              "entity_id": "T80",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 372,
              "end_idx": 375
            },
            {
              "entity_id": "T85",
              "entity": "血药浓度",
              "entity_type": "Pathogenesis",
              "start_idx": 69,
              "end_idx": 73
            },
            {
              "entity_id": "T86",
              "entity": "餐时血糖",
              "entity_type": "Test_items",
              "start_idx": 52,
              "end_idx": 56
            },
            {
              "entity_id": "T87",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 105,
              "end_idx": 107
            },
            {
              "entity_id": "T88",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 138,
              "end_idx": 141
            },
            {
              "entity_id": "T89",
              "entity": "心血管疾病",
              "entity_type": "Disease",
              "start_idx": 142,
              "end_idx": 147
            },
            {
              "entity_id": "T90",
              "entity": "心血管",
              "entity_type": "Anatomy",
              "start_idx": 142,
              "end_idx": 145
            },
            {
              "entity_id": "T91",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 192,
              "end_idx": 195
            },
            {
              "entity_id": "T92",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 353,
              "end_idx": 357
            },
            {
              "entity_id": "T93",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 353,
              "end_idx": 355
            }
          ],
          "relations": [
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R8",
              "head_entity_id": "T73",
              "tail_entity_id": "T49"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R9",
              "head_entity_id": "T74",
              "tail_entity_id": "T50"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R10",
              "head_entity_id": "T74",
              "tail_entity_id": "T51"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R11",
              "head_entity_id": "T74",
              "tail_entity_id": "T52"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R12",
              "head_entity_id": "T74",
              "tail_entity_id": "T53"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R13",
              "head_entity_id": "T75",
              "tail_entity_id": "T54"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R14",
              "head_entity_id": "T76",
              "tail_entity_id": "T55"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R15",
              "head_entity_id": "T55",
              "tail_entity_id": "T88"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R16",
              "head_entity_id": "T76",
              "tail_entity_id": "T56"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R17",
              "head_entity_id": "T56",
              "tail_entity_id": "T91"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R18",
              "head_entity_id": "T76",
              "tail_entity_id": "T57"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R19",
              "head_entity_id": "T57",
              "tail_entity_id": "T91"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R20",
              "head_entity_id": "T77",
              "tail_entity_id": "T58"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R21",
              "head_entity_id": "T78",
              "tail_entity_id": "T60"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R22",
              "head_entity_id": "T79",
              "tail_entity_id": "T61"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R23",
              "head_entity_id": "T79",
              "tail_entity_id": "T62"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R24",
              "head_entity_id": "T79",
              "tail_entity_id": "T63"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R25",
              "head_entity_id": "T80",
              "tail_entity_id": "T64"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R26",
              "head_entity_id": "T64",
              "tail_entity_id": "T92"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R27",
              "head_entity_id": "T80",
              "tail_entity_id": "T65"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R28",
              "head_entity_id": "T65",
              "tail_entity_id": "T92"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R29",
              "head_entity_id": "T80",
              "tail_entity_id": "T66"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R30",
              "head_entity_id": "T66",
              "tail_entity_id": "T92"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R35",
              "head_entity_id": "T90",
              "tail_entity_id": "T89"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R36",
              "head_entity_id": "T93",
              "tail_entity_id": "T92"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "公认的低血糖发生少的甘精胰岛素的大型研究最新结果显示，甘精胰岛素低血糖发生的风险明显高于口服药。",
          "start_idx": 400,
          "end_idx": 448,
          "entities": [
            {
              "entity_id": "T67",
              "entity": "甘精胰岛素",
              "entity_type": "Drug",
              "start_idx": 10,
              "end_idx": 15
            },
            {
              "entity_id": "T68",
              "entity": "甘精胰岛素",
              "entity_type": "Drug",
              "start_idx": 27,
              "end_idx": 32
            },
            {
              "entity_id": "T81",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 3,
              "end_idx": 6
            },
            {
              "entity_id": "T82",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 32,
              "end_idx": 35
            },
            {
              "entity_id": "T94",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 44,
              "end_idx": 46
            }
          ],
          "relations": [
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R31",
              "head_entity_id": "T81",
              "tail_entity_id": "T67"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R32",
              "head_entity_id": "T82",
              "tail_entity_id": "T68"
            }
          ]
        },
        {
          "sentence_id": "2",
          "sentence": "由此可见，胰岛素促泌剂肯定存在低血糖风险，但是胰岛素的低血糖风险更大。",
          "start_idx": 448,
          "end_idx": 483,
          "entities": [
            {
              "entity_id": "T69",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 5,
              "end_idx": 11
            },
            {
              "entity_id": "T70",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 23,
              "end_idx": 26
            },
            {
              "entity_id": "T83",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 15,
              "end_idx": 18
            },
            {
              "entity_id": "T84",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 27,
              "end_idx": 30
            }
          ],
          "relations": [
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R33",
              "head_entity_id": "T83",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R34",
              "head_entity_id": "T84",
              "tail_entity_id": "T70"
            }
          ]
        },
        {
          "sentence_id": "3",
          "sentence": "因此需要时一般情况下应优先选择胰岛素促泌剂而不是胰岛素。",
          "start_idx": 483,
          "end_idx": 511,
          "entities": [
            {
              "entity_id": "T71",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 15,
              "end_idx": 21
            },
            {
              "entity_id": "T72",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 24,
              "end_idx": 27
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "4",
          "sentence": " ",
          "start_idx": 511,
          "end_idx": 512,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "10",
      "paragraph": "2.2 体重增加明显 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.2 体重增加明显 ",
          "start_idx": 0,
          "end_idx": 11,
          "entities": [
            {
              "entity_id": "T95",
              "entity": "体重增加",
              "entity_type": "ADE",
              "start_idx": 4,
              "end_idx": 8
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "11",
      "paragraph": "目前一般认为磺脲类药物治疗可引起患者体重增加。UKPDS表明，以格列本脲为基础的降糖治疗，患者体重增加1.7kg。Schernthaner等对使用格列齐特和格列美脲治疗的患者行27周的随访发现，其体重增加分别为0.5kg和0.6kg。而ADVANCE5年的观察分析并未发现以格列齐特缓释片为基础的降糖治疗增加患者体重。很多大型研究表明胰岛素增加体重更明显，比如ADVANCE新近的分析发现用胰岛素体重增加3.3kg，而磺脲服类为0.7kg。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "目前一般认为磺脲类药物治疗可引起患者体重增加。UKPDS表明，以格列本脲为基础的降糖治疗，患者体重增加1.7kg。Schernthaner等对使用格列齐特和格列美脲治疗的患者行27周的随访发现，其体重增加分别为0.5kg和0.6kg。",
          "start_idx": 0,
          "end_idx": 117,
          "entities": [
            {
              "entity_id": "T96",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 11
            },
            {
              "entity_id": "T97",
              "entity": "格列本脲",
              "entity_type": "Drug",
              "start_idx": 32,
              "end_idx": 36
            },
            {
              "entity_id": "T98",
              "entity": "格列齐特",
              "entity_type": "Drug",
              "start_idx": 73,
              "end_idx": 77
            },
            {
              "entity_id": "T99",
              "entity": "格列美脲",
              "entity_type": "Drug",
              "start_idx": 78,
              "end_idx": 82
            },
            {
              "entity_id": "T102",
              "entity": "体重增加",
              "entity_type": "ADE",
              "start_idx": 18,
              "end_idx": 22
            },
            {
              "entity_id": "T103",
              "entity": "体重增加",
              "entity_type": "ADE",
              "start_idx": 47,
              "end_idx": 51
            },
            {
              "entity_id": "T104",
              "entity": "体重增加",
              "entity_type": "ADE",
              "start_idx": 98,
              "end_idx": 102
            }
          ],
          "relations": [
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R37",
              "head_entity_id": "T102",
              "tail_entity_id": "T96"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R38",
              "head_entity_id": "T103",
              "tail_entity_id": "T97"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R39",
              "head_entity_id": "T104",
              "tail_entity_id": "T98"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R40",
              "head_entity_id": "T104",
              "tail_entity_id": "T99"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "而ADVANCE5年的观察分析并未发现以格列齐特缓释片为基础的降糖治疗增加患者体重。",
          "start_idx": 117,
          "end_idx": 159,
          "entities": [
            {
              "entity_id": "T100",
              "entity": "格列齐特缓释片",
              "entity_type": "Drug",
              "start_idx": 20,
              "end_idx": 27
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "很多大型研究表明胰岛素增加体重更明显，比如ADVANCE新近的分析发现用胰岛素体重增加3.3kg，而磺脲服类为0.7kg。",
          "start_idx": 159,
          "end_idx": 220,
          "entities": [
            {
              "entity_id": "T101",
              "entity": "磺脲服类",
              "entity_type": "Drug",
              "start_idx": 50,
              "end_idx": 54
            },
            {
              "entity_id": "T105",
              "entity": "增加体重",
              "entity_type": "ADE",
              "start_idx": 11,
              "end_idx": 15
            },
            {
              "entity_id": "T106",
              "entity": "体重增加",
              "entity_type": "ADE",
              "start_idx": 39,
              "end_idx": 43
            },
            {
              "entity_id": "T107",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 11
            },
            {
              "entity_id": "T108",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 36,
              "end_idx": 39
            }
          ],
          "relations": [
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R41",
              "head_entity_id": "T105",
              "tail_entity_id": "T107"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R42",
              "head_entity_id": "T106",
              "tail_entity_id": "T108"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "12",
      "paragraph": "不难看出，胰岛素促泌剂增加体重，但胰岛素体重增加更明显。表明超重和肥胖的糖尿病患者选用降药时一般也应是胰岛素促泌剂优于胰岛素。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "不难看出，胰岛素促泌剂增加体重，但胰岛素体重增加更明显。表明超重和肥胖的糖尿病患者选用降药时一般也应是胰岛素促泌剂优于胰岛素。",
          "start_idx": 0,
          "end_idx": 63,
          "entities": [
            {
              "entity_id": "T109",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 5,
              "end_idx": 11
            },
            {
              "entity_id": "T110",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 17,
              "end_idx": 20
            },
            {
              "entity_id": "T111",
              "entity": "超重",
              "entity_type": "Drug",
              "start_idx": 30,
              "end_idx": 32
            },
            {
              "entity_id": "T112",
              "entity": "肥胖",
              "entity_type": "Drug",
              "start_idx": 33,
              "end_idx": 35
            },
            {
              "entity_id": "T113",
              "entity": "糖尿病",
              "entity_type": "Drug",
              "start_idx": 36,
              "end_idx": 39
            },
            {
              "entity_id": "T114",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 51,
              "end_idx": 57
            },
            {
              "entity_id": "T115",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 59,
              "end_idx": 62
            },
            {
              "entity_id": "T116",
              "entity": "增加体重",
              "entity_type": "ADE",
              "start_idx": 11,
              "end_idx": 15
            },
            {
              "entity_id": "T117",
              "entity": "体重增加",
              "entity_type": "ADE",
              "start_idx": 20,
              "end_idx": 24
            }
          ],
          "relations": [
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R43",
              "head_entity_id": "T116",
              "tail_entity_id": "T109"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R44",
              "head_entity_id": "T117",
              "tail_entity_id": "T110"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 63,
          "end_idx": 64,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "13",
      "paragraph": "2.3加重β细胞功能衰竭",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.3加重β细胞功能衰竭",
          "start_idx": 0,
          "end_idx": 12,
          "entities": [
            {
              "entity_id": "T118",
              "entity": "β细胞功能衰竭",
              "entity_type": "Pathogenesis",
              "start_idx": 5,
              "end_idx": 12
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "14",
      "paragraph": "有研究认为胰岛素促泌剂可以引起胰岛β细胞凋亡，且促凋亡作用呈时间-剂量依赖性增加。UKPDS的结果显示，无论使用何种降糖治疗，胰岛β细胞功能每年以约7%的速度丧失，使用格列本脲和氯磺丙脲治疗的患者β细胞胰岛素分泌功能有下降趋势，但与采用二甲双胍治疗和单纯饮食控制相似。糖尿病进展试验(ADOPT)对比了3种不同类型降糖药物(罗格列酮、格列本脲和二甲双胍)在新诊断T2DM患者中的疗效，发现格列本脲改善β细胞胰岛素分泌功能明显优于罗格列酮和二甲双胍，并非发现磺脲类药物加重或加速了β细胞的衰竭。迄今的循证医学证据没有发现映岛素促泌剂加重或加速β细胞衰竭。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "有研究认为胰岛素促泌剂可以引起胰岛β细胞凋亡，且促凋亡作用呈时间-剂量依赖性增加。UKPDS的结果显示，无论使用何种降糖治疗，胰岛β细胞功能每年以约7%的速度丧失，使用格列本脲和氯磺丙脲治疗的患者β细胞胰岛素分泌功能有下降趋势，但与采用二甲双胍治疗和单纯饮食控制相似。糖尿病进展试验(ADOPT)对比了3种不同类型降糖药物(罗格列酮、格列本脲和二甲双胍)在新诊断T2DM患者中的疗效，发现格列本脲改善β细胞胰岛素分泌功能明显优于罗格列酮和二甲双胍，并非发现磺脲类药物加重或加速了β细胞的衰竭。",
          "start_idx": 0,
          "end_idx": 246,
          "entities": [
            {
              "entity_id": "T119",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 5,
              "end_idx": 11
            },
            {
              "entity_id": "T120",
              "entity": "格列本脲",
              "entity_type": "Drug",
              "start_idx": 84,
              "end_idx": 88
            },
            {
              "entity_id": "T121",
              "entity": "氯磺丙脲",
              "entity_type": "Drug",
              "start_idx": 89,
              "end_idx": 93
            },
            {
              "entity_id": "T122",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 118,
              "end_idx": 122
            },
            {
              "entity_id": "T123",
              "entity": "罗格列酮",
              "entity_type": "Drug",
              "start_idx": 162,
              "end_idx": 166
            },
            {
              "entity_id": "T124",
              "entity": "格列本脲",
              "entity_type": "Drug",
              "start_idx": 167,
              "end_idx": 171
            },
            {
              "entity_id": "T125",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 172,
              "end_idx": 176
            },
            {
              "entity_id": "T126",
              "entity": "格列本脲",
              "entity_type": "Drug",
              "start_idx": 194,
              "end_idx": 198
            },
            {
              "entity_id": "T127",
              "entity": "罗格列酮",
              "entity_type": "Drug",
              "start_idx": 214,
              "end_idx": 218
            },
            {
              "entity_id": "T128",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 219,
              "end_idx": 223
            },
            {
              "entity_id": "T129",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 228,
              "end_idx": 233
            },
            {
              "entity_id": "T131",
              "entity": "胰岛β细胞凋亡",
              "entity_type": "Pathogenesis",
              "start_idx": 15,
              "end_idx": 22
            },
            {
              "entity_id": "T132",
              "entity": "β细胞的衰竭",
              "entity_type": "Pathogenesis",
              "start_idx": 239,
              "end_idx": 245
            },
            {
              "entity_id": "T134",
              "entity": "单纯饮食控制",
              "entity_type": "Treatment",
              "start_idx": 125,
              "end_idx": 131
            },
            {
              "entity_id": "T135",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 134,
              "end_idx": 137
            },
            {
              "entity_id": "T136",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 181,
              "end_idx": 185
            },
            {
              "entity_id": "T137",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 181,
              "end_idx": 183
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R45",
              "head_entity_id": "T123",
              "tail_entity_id": "T135"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R46",
              "head_entity_id": "T124",
              "tail_entity_id": "T135"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R47",
              "head_entity_id": "T125",
              "tail_entity_id": "T135"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R48",
              "head_entity_id": "T137",
              "tail_entity_id": "T136"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "迄今的循证医学证据没有发现映岛素促泌剂加重或加速β细胞衰竭。",
          "start_idx": 246,
          "end_idx": 276,
          "entities": [
            {
              "entity_id": "T130",
              "entity": "映岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 13,
              "end_idx": 19
            },
            {
              "entity_id": "T133",
              "entity": "β细胞衰竭",
              "entity_type": "Pathogenesis",
              "start_idx": 24,
              "end_idx": 29
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 276,
          "end_idx": 277,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "15",
      "paragraph": "2.4 心血管风险 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.4 心血管风险 ",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [
            {
              "entity_id": "T138",
              "entity": "心血管风险",
              "entity_type": "Disease",
              "start_idx": 4,
              "end_idx": 9
            },
            {
              "entity_id": "T139",
              "entity": "心血管",
              "entity_type": "Anatomy",
              "start_idx": 4,
              "end_idx": 7
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R49",
              "head_entity_id": "T139",
              "tail_entity_id": "T138"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "16",
      "paragraph": "美国大学组糖尿病研究项目(UGDP)研究提出，甲苯磺丁脲可能增加T2DM患者心血管死亡风险。UKPDS随机给予新发T2DM患者胰岛素注射或口服降糖药治疗，以了解不同治疗方式对心血管并发症的影响。结果显示，磺脲类药物未增加心血管并发症发生；相反，其后续研究发现磺脲类可减少心血管事件发生。ADVANCE对病程较长，合并心血管高危因素的T2DM患者采用以格列齐特缓释片为基础的降糖治疗，主要微血管事件减少14%。Meta分析结果显示，以氯磺丙脲、格列本脲和格列齐特缓释片为基础的降糖治疗可使T2DM患者非致死性心肌梗死风险降低17%、冠心病风险降低15%。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "美国大学组糖尿病研究项目(UGDP)研究提出，甲苯磺丁脲可能增加T2DM患者心血管死亡风险。UKPDS随机给予新发T2DM患者胰岛素注射或口服降糖药治疗，以了解不同治疗方式对心血管并发症的影响。结果显示，磺脲类药物未增加心血管并发症发生；相反，其后续研究发现磺脲类可减少心血管事件发生。ADVANCE对病程较长，合并心血管高危因素的T2DM患者采用以格列齐特缓释片为基础的降糖治疗，主要微血管事件减少14%。Meta分析结果显示，以氯磺丙脲、格列本脲和格列齐特缓释片为基础的降糖治疗可使T2DM患者非致死性心肌梗死风险降低17%、冠心病风险降低15%。",
          "start_idx": 0,
          "end_idx": 276,
          "entities": [
            {
              "entity_id": "T140",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 5,
              "end_idx": 8
            },
            {
              "entity_id": "T141",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 32,
              "end_idx": 36
            },
            {
              "entity_id": "T142",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 57,
              "end_idx": 61
            },
            {
              "entity_id": "T143",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 166,
              "end_idx": 170
            },
            {
              "entity_id": "T144",
              "entity": "T2DM患者",
              "entity_type": "Disease",
              "start_idx": 243,
              "end_idx": 249
            },
            {
              "entity_id": "T145",
              "entity": "心肌梗死",
              "entity_type": "Disease",
              "start_idx": 253,
              "end_idx": 257
            },
            {
              "entity_id": "T146",
              "entity": "冠心病",
              "entity_type": "Disease",
              "start_idx": 265,
              "end_idx": 268
            },
            {
              "entity_id": "T147",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 32,
              "end_idx": 34
            },
            {
              "entity_id": "T148",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 57,
              "end_idx": 59
            },
            {
              "entity_id": "T149",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 166,
              "end_idx": 168
            },
            {
              "entity_id": "T150",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 243,
              "end_idx": 245
            },
            {
              "entity_id": "T151",
              "entity": "甲苯磺丁脲",
              "entity_type": "Drug",
              "start_idx": 23,
              "end_idx": 28
            },
            {
              "entity_id": "T152",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 63,
              "end_idx": 66
            },
            {
              "entity_id": "T153",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 102,
              "end_idx": 107
            },
            {
              "entity_id": "T154",
              "entity": "磺脲类",
              "entity_type": "Drug",
              "start_idx": 129,
              "end_idx": 132
            },
            {
              "entity_id": "T155",
              "entity": "格列齐特缓释片",
              "entity_type": "Drug",
              "start_idx": 175,
              "end_idx": 182
            },
            {
              "entity_id": "T156",
              "entity": "氯磺丙脲",
              "entity_type": "Drug",
              "start_idx": 216,
              "end_idx": 220
            },
            {
              "entity_id": "T157",
              "entity": "格列本脲",
              "entity_type": "Drug",
              "start_idx": 221,
              "end_idx": 225
            },
            {
              "entity_id": "T158",
              "entity": "格列齐特缓释片",
              "entity_type": "Drug",
              "start_idx": 226,
              "end_idx": 233
            },
            {
              "entity_id": "T159",
              "entity": "心血管并发症",
              "entity_type": "ADE",
              "start_idx": 87,
              "end_idx": 93
            },
            {
              "entity_id": "T160",
              "entity": "心血管死亡",
              "entity_type": "ADE",
              "start_idx": 38,
              "end_idx": 43
            },
            {
              "entity_id": "T161",
              "entity": "心血管并发症",
              "entity_type": "ADE",
              "start_idx": 110,
              "end_idx": 116
            },
            {
              "entity_id": "T162",
              "entity": "心血管事件",
              "entity_type": "ADE",
              "start_idx": 135,
              "end_idx": 140
            },
            {
              "entity_id": "T163",
              "entity": "微血管事件",
              "entity_type": "ADE",
              "start_idx": 193,
              "end_idx": 198
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R50",
              "head_entity_id": "T147",
              "tail_entity_id": "T141"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R51",
              "head_entity_id": "T151",
              "tail_entity_id": "T141"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R52",
              "head_entity_id": "T148",
              "tail_entity_id": "T142"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R53",
              "head_entity_id": "T152",
              "tail_entity_id": "T142"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R54",
              "head_entity_id": "T149",
              "tail_entity_id": "T143"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R55",
              "head_entity_id": "T155",
              "tail_entity_id": "T143"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R56",
              "head_entity_id": "T150",
              "tail_entity_id": "T144"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R57",
              "head_entity_id": "T156",
              "tail_entity_id": "T144"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R58",
              "head_entity_id": "T157",
              "tail_entity_id": "T144"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R59",
              "head_entity_id": "T158",
              "tail_entity_id": "T144"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R60",
              "head_entity_id": "T160",
              "tail_entity_id": "T151"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R61",
              "head_entity_id": "T159",
              "tail_entity_id": "T152"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "17",
      "paragraph": "现有的证据表明，胰岛素促泌剂中的磺脲类药物有利于保护T2DM的心血管，没有随机双盲前瞻性长时间研究发现它增加心血管风险。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "现有的证据表明，胰岛素促泌剂中的磺脲类药物有利于保护T2DM的心血管，没有随机双盲前瞻性长时间研究发现它增加心血管风险。",
          "start_idx": 0,
          "end_idx": 60,
          "entities": [
            {
              "entity_id": "T164",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 14
            },
            {
              "entity_id": "T165",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 16,
              "end_idx": 21
            },
            {
              "entity_id": "T166",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 26,
              "end_idx": 30
            },
            {
              "entity_id": "T167",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 26,
              "end_idx": 28
            },
            {
              "entity_id": "T168",
              "entity": "心血管风险",
              "entity_type": "ADE",
              "start_idx": 54,
              "end_idx": 59
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R62",
              "head_entity_id": "T167",
              "tail_entity_id": "T166"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 60,
          "end_idx": 61,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "18",
      "paragraph": "2.5 肿瘤风险 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.5 肿瘤风险 ",
          "start_idx": 0,
          "end_idx": 9,
          "entities": [
            {
              "entity_id": "T169",
              "entity": "肿瘤",
              "entity_type": "Disease",
              "start_idx": 4,
              "end_idx": 6
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "19",
      "paragraph": "有研究表明T2DM患者的肿瘤风险增加，甚至某些回顾性的资料分析发现磺脲类药物可能增加肿瘤的风险，但高水平高级别的证据如从UKPDS到近期发表的ADVANCE亚组分析均未发现磺脲类药物增加患者肿瘤风险。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "有研究表明T2DM患者的肿瘤风险增加，甚至某些回顾性的资料分析发现磺脲类药物可能增加肿瘤的风险，但高水平高级别的证据如从UKPDS到近期发表的ADVANCE亚组分析均未发现磺脲类药物增加患者肿瘤风险。",
          "start_idx": 0,
          "end_idx": 100,
          "entities": [
            {
              "entity_id": "T170",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 5,
              "end_idx": 9
            },
            {
              "entity_id": "T171",
              "entity": "肿瘤",
              "entity_type": "Disease",
              "start_idx": 95,
              "end_idx": 97
            },
            {
              "entity_id": "T172",
              "entity": "肿瘤",
              "entity_type": "Disease",
              "start_idx": 42,
              "end_idx": 44
            },
            {
              "entity_id": "T173",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 5,
              "end_idx": 7
            },
            {
              "entity_id": "T174",
              "entity": "肿瘤",
              "entity_type": "Disease",
              "start_idx": 12,
              "end_idx": 14
            },
            {
              "entity_id": "T175",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 33,
              "end_idx": 38
            },
            {
              "entity_id": "T176",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 86,
              "end_idx": 91
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R63",
              "head_entity_id": "T173",
              "tail_entity_id": "T170"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "20",
      "paragraph": "3 胰岛素促泌剂的临床应用 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3 胰岛素促泌剂的临床应用 ",
          "start_idx": 0,
          "end_idx": 14,
          "entities": [
            {
              "entity_id": "T177",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 8
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "21",
      "paragraph": "共识强调胰岛素促泌剂仍是治疗T2DM的一线药，对于有一定β细胞功能、无胰岛素促泌剂应用禁忌的T2DM患者均可考虑选用胰岛素促泌剂。对无超重和肥胖或二甲双胍不耐受者或其他口服降糖药物治疗血糖控制不佳的T2DM患者促泌剂可作为首选或联合药物。应根据患者血糖谱选择不同类型的胰岛素促泌剂：以餐后血糖(PPG)升高为主者宜选择格列奈类及短效磺脲类促泌剂；以空腹血糖(FPG)升高为主PPG和FPG均升高者宜选择依从性好、低血糖风险低的中长效磺脲类促泌剂。若单药治疗血糖控制不达标，应与其他口服降糖药联用，一般联合两种药物，最多可联用3种药物。胰岛素促泌剂可与基础胰岛素合用，但不主张与格列奈类合用。胰岛素促泌剂与其他药物联合使用时应选择作用机制互补的降糖药物，这样既增强药物降糖效果又减少了各自的剂量及体重增加、严重低血糖等不良反应的发生率，同时要评估联合用药的成本-效益因素，充分考虑患者的经济承受能力和用药的依从性，特别是经济欠发达和农村地区患者。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "共识强调胰岛素促泌剂仍是治疗T2DM的一线药，对于有一定β细胞功能、无胰岛素促泌剂应用禁忌的T2DM患者均可考虑选用胰岛素促泌剂。对无超重和肥胖或二甲双胍不耐受者或其他口服降糖药物治疗血糖控制不佳的T2DM患者促泌剂可作为首选或联合药物。应根据患者血糖谱选择不同类型的胰岛素促泌剂：以餐后血糖(PPG)升高为主者宜选择格列奈类及短效磺脲类促泌剂；以空腹血糖(FPG)升高为主PPG和FPG均升高者宜选择依从性好、低血糖风险低的中长效磺脲类促泌剂。",
          "start_idx": 0,
          "end_idx": 223,
          "entities": [
            {
              "entity_id": "T178",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 4,
              "end_idx": 10
            },
            {
              "entity_id": "T179",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 58,
              "end_idx": 64
            },
            {
              "entity_id": "T180",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 73,
              "end_idx": 77
            },
            {
              "entity_id": "T181",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 134,
              "end_idx": 140
            },
            {
              "entity_id": "T182",
              "entity": "格列奈类",
              "entity_type": "Drug",
              "start_idx": 159,
              "end_idx": 163
            },
            {
              "entity_id": "T183",
              "entity": "短效磺脲类促泌剂",
              "entity_type": "Drug",
              "start_idx": 164,
              "end_idx": 172
            },
            {
              "entity_id": "T184",
              "entity": "中长效磺脲类促泌剂",
              "entity_type": "Drug",
              "start_idx": 213,
              "end_idx": 222
            },
            {
              "entity_id": "T189",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 14,
              "end_idx": 18
            },
            {
              "entity_id": "T190",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 46,
              "end_idx": 50
            },
            {
              "entity_id": "T191",
              "entity": "超重",
              "entity_type": "Disease",
              "start_idx": 67,
              "end_idx": 69
            },
            {
              "entity_id": "T192",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 70,
              "end_idx": 72
            },
            {
              "entity_id": "T193",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 99,
              "end_idx": 103
            },
            {
              "entity_id": "T194",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 14,
              "end_idx": 16
            },
            {
              "entity_id": "T195",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 46,
              "end_idx": 48
            },
            {
              "entity_id": "T196",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 99,
              "end_idx": 101
            },
            {
              "entity_id": "T197",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 35,
              "end_idx": 41
            },
            {
              "entity_id": "T198",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 84,
              "end_idx": 86
            },
            {
              "entity_id": "T200",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 92,
              "end_idx": 94
            },
            {
              "entity_id": "T201",
              "entity": "血糖谱",
              "entity_type": "Test_items",
              "start_idx": 124,
              "end_idx": 127
            },
            {
              "entity_id": "T202",
              "entity": "餐后血糖(PPG)",
              "entity_type": "Test_items",
              "start_idx": 142,
              "end_idx": 151
            },
            {
              "entity_id": "T203",
              "entity": "空腹血糖(FPG)",
              "entity_type": "Test_items",
              "start_idx": 174,
              "end_idx": 183
            },
            {
              "entity_id": "T204",
              "entity": "PPG",
              "entity_type": "Test_items",
              "start_idx": 187,
              "end_idx": 190
            },
            {
              "entity_id": "T205",
              "entity": "FPG",
              "entity_type": "Test_items",
              "start_idx": 191,
              "end_idx": 194
            },
            {
              "entity_id": "T207",
              "entity": "控制不佳",
              "entity_type": "Test_Value",
              "start_idx": 94,
              "end_idx": 98
            },
            {
              "entity_id": "T208",
              "entity": "升高",
              "entity_type": "Test_Value",
              "start_idx": 151,
              "end_idx": 153
            },
            {
              "entity_id": "T209",
              "entity": "升高",
              "entity_type": "Test_Value",
              "start_idx": 183,
              "end_idx": 185
            },
            {
              "entity_id": "T210",
              "entity": "均升高",
              "entity_type": "Test_Value",
              "start_idx": 194,
              "end_idx": 197
            },
            {
              "entity_id": "T212",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 206,
              "end_idx": 209
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R64",
              "head_entity_id": "T178",
              "tail_entity_id": "T189"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R65",
              "head_entity_id": "T179",
              "tail_entity_id": "T190"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R66",
              "head_entity_id": "T181",
              "tail_entity_id": "T193"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R67",
              "head_entity_id": "T212",
              "tail_entity_id": "T184"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R68",
              "head_entity_id": "T194",
              "tail_entity_id": "T189"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R69",
              "head_entity_id": "T195",
              "tail_entity_id": "T190"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R70",
              "head_entity_id": "T196",
              "tail_entity_id": "T193"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R71",
              "head_entity_id": "T200",
              "tail_entity_id": "T193"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "若单药治疗血糖控制不达标，应与其他口服降糖药联用，一般联合两种药物，最多可联用3种药物。",
          "start_idx": 223,
          "end_idx": 267,
          "entities": [
            {
              "entity_id": "T199",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 17,
              "end_idx": 19
            },
            {
              "entity_id": "T206",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 5,
              "end_idx": 7
            },
            {
              "entity_id": "T211",
              "entity": "控制不达标",
              "entity_type": "Test_Value",
              "start_idx": 7,
              "end_idx": 12
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "胰岛素促泌剂可与基础胰岛素合用，但不主张与格列奈类合用。",
          "start_idx": 267,
          "end_idx": 295,
          "entities": [
            {
              "entity_id": "T185",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 6
            },
            {
              "entity_id": "T186",
              "entity": "基础胰岛素",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 13
            },
            {
              "entity_id": "T187",
              "entity": "格列奈类",
              "entity_type": "Drug",
              "start_idx": 21,
              "end_idx": 25
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "3",
          "sentence": "胰岛素促泌剂与其他药物联合使用时应选择作用机制互补的降糖药物，这样既增强药物降糖效果又减少了各自的剂量及体重增加、严重低血糖等不良反应的发生率，同时要评估联合用药的成本-效益因素，充分考虑患者的经济承受能力和用药的依从性，特别是经济欠发达和农村地区患者。",
          "start_idx": 295,
          "end_idx": 422,
          "entities": [
            {
              "entity_id": "T188",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 6
            },
            {
              "entity_id": "T213",
              "entity": "体重增加",
              "entity_type": "ADE",
              "start_idx": 52,
              "end_idx": 56
            },
            {
              "entity_id": "T214",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 59,
              "end_idx": 62
            },
            {
              "entity_id": "T215",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 57,
              "end_idx": 59
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "4",
          "sentence": " ",
          "start_idx": 422,
          "end_idx": 423,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "22",
      "paragraph": "胰岛素促泌剂的降糖作用在常规剂量内呈剂量依赖性，可平均将糖化血红蛋白(HbA1c)水平降低2%左右，且患者的基线HbA1c水平越高，服用胰鸟素促泌剂治疗后HbA1c的降幅越大。剂量应从小量开始，以减少低血糖发生。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "胰岛素促泌剂的降糖作用在常规剂量内呈剂量依赖性，可平均将糖化血红蛋白(HbA1c)水平降低2%左右，且患者的基线HbA1c水平越高，服用胰鸟素促泌剂治疗后HbA1c的降幅越大。",
          "start_idx": 0,
          "end_idx": 88,
          "entities": [
            {
              "entity_id": "T216",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 6
            },
            {
              "entity_id": "T217",
              "entity": "胰鸟素促泌剂",
              "entity_type": "Drug",
              "start_idx": 68,
              "end_idx": 74
            },
            {
              "entity_id": "T218",
              "entity": "糖化血红蛋白(HbA1c)",
              "entity_type": "Test_items",
              "start_idx": 28,
              "end_idx": 41
            },
            {
              "entity_id": "T219",
              "entity": "基线HbA1c",
              "entity_type": "Test_items",
              "start_idx": 54,
              "end_idx": 61
            },
            {
              "entity_id": "T220",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 77,
              "end_idx": 82
            },
            {
              "entity_id": "T221",
              "entity": "降低2%左右",
              "entity_type": "Test_Value",
              "start_idx": 43,
              "end_idx": 49
            },
            {
              "entity_id": "T222",
              "entity": "高",
              "entity_type": "Test_Value",
              "start_idx": 64,
              "end_idx": 65
            },
            {
              "entity_id": "T223",
              "entity": "降幅越大",
              "entity_type": "Test_Value",
              "start_idx": 83,
              "end_idx": 87
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "剂量应从小量开始，以减少低血糖发生。",
          "start_idx": 88,
          "end_idx": 106,
          "entities": [
            {
              "entity_id": "T224",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 12,
              "end_idx": 15
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 106,
          "end_idx": 107,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "23",
      "paragraph": "中或重度肝肾功能不全者不宜使用胰岛素促泌剂。轻中度肾功能不全者若不用胰岛素，需要用胰岛素促泌剂时可考虑瑞格列奈和格列喹酮。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "中或重度肝肾功能不全者不宜使用胰岛素促泌剂。轻中度肾功能不全者若不用胰岛素，需要用胰岛素促泌剂时可考虑瑞格列奈和格列喹酮。",
          "start_idx": 0,
          "end_idx": 61,
          "entities": [
            {
              "entity_id": "T225",
              "entity": "肝肾功能不全",
              "entity_type": "Disease",
              "start_idx": 4,
              "end_idx": 10
            },
            {
              "entity_id": "T226",
              "entity": "肝",
              "entity_type": "Anatomy",
              "start_idx": 4,
              "end_idx": 5
            },
            {
              "entity_id": "T227",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 5,
              "end_idx": 6
            },
            {
              "entity_id": "T228",
              "entity": "中或重度",
              "entity_type": "Level",
              "start_idx": 0,
              "end_idx": 4
            },
            {
              "entity_id": "T229",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 15,
              "end_idx": 21
            },
            {
              "entity_id": "T230",
              "entity": "肾功能不全",
              "entity_type": "Disease",
              "start_idx": 25,
              "end_idx": 30
            },
            {
              "entity_id": "T231",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 25,
              "end_idx": 26
            },
            {
              "entity_id": "T232",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 34,
              "end_idx": 37
            },
            {
              "entity_id": "T233",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 41,
              "end_idx": 47
            },
            {
              "entity_id": "T234",
              "entity": "瑞格列奈",
              "entity_type": "Drug",
              "start_idx": 51,
              "end_idx": 55
            },
            {
              "entity_id": "T235",
              "entity": "格列喹酮",
              "entity_type": "Drug",
              "start_idx": 56,
              "end_idx": 60
            },
            {
              "entity_id": "T236",
              "entity": "轻中度",
              "entity_type": "Level",
              "start_idx": 22,
              "end_idx": 25
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R72",
              "head_entity_id": "T226",
              "tail_entity_id": "T225"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R73",
              "head_entity_id": "T227",
              "tail_entity_id": "T225"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R74",
              "head_entity_id": "T231",
              "tail_entity_id": "T230"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R75",
              "head_entity_id": "T233",
              "tail_entity_id": "T230"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R76",
              "head_entity_id": "T234",
              "tail_entity_id": "T230"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R77",
              "head_entity_id": "T235",
              "tail_entity_id": "T230"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "24",
      "paragraph": "总之，胰岛素促泌剂符合中国2型糖尿病的特点，是多数权威指南推荐的治疗2型糖尿病的一线药物。磺脲类药物应用时间长、降糖效果强、安全性高、价格低廉，早期使用可减少大血管、微血管、并发症和全因死亡的发生。格列奈类有效降低餐后血糖，在中国也广泛使用。临床医生应以循证医学研究的证据来科学评价胰岛素促泌剂，同时应充分了解各种药物的特点，结合患者的血糖谱、年龄、病程、肝肾功能、胰岛功能、依从性、经济条件等情况综合考虑，制定个体化的用药方案，使患者血糖安全达标的同时减少不良反应的发生，延缓疾病进程，减少并发症，提高患者的生活质量。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "总之，胰岛素促泌剂符合中国2型糖尿病的特点，是多数权威指南推荐的治疗2型糖尿病的一线药物。",
          "start_idx": 0,
          "end_idx": 45,
          "entities": [
            {
              "entity_id": "T237",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 9
            },
            {
              "entity_id": "T241",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 13,
              "end_idx": 18
            },
            {
              "entity_id": "T242",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 34,
              "end_idx": 39
            },
            {
              "entity_id": "T243",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 13,
              "end_idx": 15
            },
            {
              "entity_id": "T244",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 34,
              "end_idx": 36
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R78",
              "head_entity_id": "T243",
              "tail_entity_id": "T241"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R79",
              "head_entity_id": "T244",
              "tail_entity_id": "T242"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "磺脲类药物应用时间长、降糖效果强、安全性高、价格低廉，早期使用可减少大血管、微血管、并发症和全因死亡的发生。",
          "start_idx": 45,
          "end_idx": 99,
          "entities": [
            {
              "entity_id": "T238",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 5
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "格列奈类有效降低餐后血糖，在中国也广泛使用。",
          "start_idx": 99,
          "end_idx": 121,
          "entities": [
            {
              "entity_id": "T239",
              "entity": "格列奈类",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4
            },
            {
              "entity_id": "T245",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 8,
              "end_idx": 12
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "3",
          "sentence": "临床医生应以循证医学研究的证据来科学评价胰岛素促泌剂，同时应充分了解各种药物的特点，结合患者的血糖谱、年龄、病程、肝肾功能、胰岛功能、依从性、经济条件等情况综合考虑，制定个体化的用药方案，使患者血糖安全达标的同时减少不良反应的发生，延缓疾病进程，减少并发症，提高患者的生活质量。",
          "start_idx": 121,
          "end_idx": 260,
          "entities": [
            {
              "entity_id": "T240",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 20,
              "end_idx": 26
            },
            {
              "entity_id": "T246",
              "entity": "血糖谱",
              "entity_type": "Test_items",
              "start_idx": 47,
              "end_idx": 50
            },
            {
              "entity_id": "T247",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 97,
              "end_idx": 99
            },
            {
              "entity_id": "T248",
              "entity": "安全达标",
              "entity_type": "Test_Value",
              "start_idx": 99,
              "end_idx": 103
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "4",
          "sentence": " ",
          "start_idx": 260,
          "end_idx": 261,
          "entities": [],
          "relations": []
        }
      ]
    }
  ]
}